Congenital heart defects may be linked to increased cancer risk in babies and mothers

FHS
March 17, 2025
11:32 am

Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Association’s flagship journal Circulation.

CHOP study uncovers metabolic key to faster immune response

Researchers from Children’s Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why

March 15, 2024

FDA Approves New First-Line Standard of Care in Bladder Cancer

Patients with locally advanced or metastatic bladder cancer have a permanent new first-line standard of care after the FDA granted full approval to the combination

December 16, 2023

Risk Adjusted Net Present Value: What is the current valuation of AstraZeneca’s Rilvegostomig

The revenue for Rilvegostomig is expected to reach an annual total of $103 mn by 2039 in the US based off GlobalData’s Expiry Model. The

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.